APO M250 (Mycophenolate mofetil 250 mg)

This pill with imprint "APO M250" is Blue & Pink, Capsule-shape and has been identified as Mycophenolate mofetil 250 mg. It is manufactured by Apotex Corp..

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; pulmonary fibrosis; myasthenia gravis; systemic lupus erythematosus; autoimmune hepatitis (and more), and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Mycophenolate mofetil

Imprint:

APO M250

Strength:

250 mg

Color:

Blue & Pink

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Selective immunosuppressants

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Manufacturer:

Apotex Corp.

National Drug Code (NDC):

60505-2968

Inactive Ingredients:

croscarmellose sodium
magnesium stearate
gelatin
sodium lauryl sulfate
ferric oxide red
titanium dioxide
indigotindisulfonate sodium
shellac
alcohol
isopropyl alcohol
butyl alcohol
propylene glycol
ammonia
ferrosoferric oxide
potassium hydroxide
water

Note: Inactive ingredients may vary.

Imprint Code FAQ's

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
68084-0587	Amerisource Health Services

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.